• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Port Info

• Ships in Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• The Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

NEW DELHI: Cipla Ltd has launched a new treatment for arthritis in technical collaboration with California-based Cymbiotics Inc.

The company will market Mobix capsules and Mobix topical cream for treatment of osteoarthritis and rheumatoid arthritis.

In a company statement, Mr Amar Lulla, Managing Director, Cipla, said, "The medical profession desires safe and effective treatments for chronic diseases such as arthritis. Recently, the withdrawal of some cox-2 inhibitors from the pharmaceutical marketplace has created a real need for products that will safely relieve the pain and debilitating effects of arthritis. Mobix is filling this need."

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Venus plans to export water heaters to S-E Asian markets

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line